5% Hydroquinone with Non-ablative fractional 1540 Erbium YAG Laser in the Treatment of Melasma
Phase 2
- Conditions
- melasma.Chloasma
- Registration Number
- IRCT2017061727097N3
- Lead Sponsor
- Vice chanscellor for research, Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 40
Inclusion Criteria
Patients with moderate to severe melasma; patients with type 2 to 4 Fitzpatrick moderate to severe melasma, patients with mental health who are able to give information in the research process; patients with their complete satisfaction to participate in the study. Exclusion criteria: patients with dermatitis in the place; Patients with unrealistic demands and expectations of treatment; Patients taking isotretinoin in the last 6 months; pregnant women; patients with a history of keloid; lactating women.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pigmentation. Timepoint: Before the study, Five months after the study. Method of measurement: Clinical examination.
- Secondary Outcome Measures
Name Time Method Complications. Timepoint: Before the study, Five months after the study. Method of measurement: Clinical examination.